OABI
OmniAb, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.33
−8.84%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+80.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 3, 2026 | Nwachuku Amechi Ekeke · officer: Chief Operating Officer | A-Award | 800,000 | $1.98 |
| Jun 18, 2026 | Love Steven · director | A-Award | 20,000 | $0.00 |
| Jun 18, 2026 | Bertozzi Carolyn R · director | M-Exempt | 20,000 | $0.00 |
| Jun 18, 2026 | Love Steven · director | M-Exempt | 20,000 | $0.00 |
| Jun 18, 2026 | HIGGINS JOHN L · director | A-Award | 40,000 | $2.03 |
| Jun 18, 2026 | HIGGINS JOHN L · director | A-Award | 20,000 | $0.00 |
| Jun 18, 2026 | HIGGINS JOHN L · director | M-Exempt | 20,000 | $0.00 |
| Jun 18, 2026 | Gotwals Philip J · director | A-Award | 40,000 | $2.03 |
| Jun 18, 2026 | Gotwals Philip J · director | A-Award | 20,000 | $0.00 |
| Jun 18, 2026 | Love Steven · director | A-Award | 40,000 | $2.03 |
| Jun 18, 2026 | Gotwals Philip J · director | M-Exempt | 20,000 | $0.00 |
| Jun 18, 2026 | Bertozzi Carolyn R · director | A-Award | 40,000 | $2.03 |
| Jun 18, 2026 | Bertozzi Carolyn R · director | A-Award | 20,000 | $0.00 |
| Jun 18, 2026 | Crouse Steven C. · director | A-Award | 40,000 | $2.03 |
| Jun 18, 2026 | Crouse Steven C. · director | A-Award | 20,000 | $0.00 |
| Jun 18, 2026 | Crouse Steven C. · director | M-Exempt | 20,000 | $0.00 |
| Jun 18, 2026 | Cochran Jennifer R. · director | A-Award | 40,000 | $2.03 |
| Jun 18, 2026 | Cochran Jennifer R. · director | A-Award | 20,000 | $0.00 |
| Jun 18, 2026 | Cochran Jennifer R. · director | M-Exempt | 20,000 | $0.00 |
| Apr 21, 2026 | Gotwals Philip J · director | M-Exempt | 13,333 | $0.00 |
| Apr 21, 2026 | Crouse Steven C. · director | M-Exempt | 13,333 | $0.00 |
| Apr 7, 2026 | GUSTAFSON KURT A · officer: Executive VP, Finance and CFO | M-Exempt | 13,542 | $0.00 |
| Apr 7, 2026 | Berkman Charles S · officer: Chief Legal Officer | M-Exempt | 13,542 | $0.00 |
| Apr 7, 2026 | GUSTAFSON KURT A · officer: Executive VP, Finance and CFO | Sale | 6,913 | $1.49 |
| Apr 7, 2026 | Berkman Charles S · officer: Chief Legal Officer | Sale | 7,157 | $1.49 |
| Apr 7, 2026 | FOEHR MATTHEW W · director, officer: President and CEO | Sale | 19,244 | $1.49 |
| Apr 7, 2026 | FOEHR MATTHEW W · director, officer: President and CEO | M-Exempt | 36,459 | $0.00 |
| Feb 18, 2026 | GUSTAFSON KURT A · officer: Executive VP, Finance and CFO | A-Award | 60,000 | $0.00 |
| Feb 18, 2026 | FOEHR MATTHEW W · director, officer: President and CEO | M-Exempt | 58,333 | $0.00 |
| Feb 18, 2026 | GUSTAFSON KURT A · officer: Executive VP, Finance and CFO | A-Award | 600,000 | $1.71 |
Institutional positioning
13F filings over the trailing two quarters
New 25Increased 40Reduced 43Sold out 128
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WHITEFORT CAPITAL MANAGEMENT, LP | Unchanged | 14,223,658 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 8,106,881 | May 13, 2026 |
| CADIAN CAPITAL MANAGEMENT, LP | Reduced | 4,157,129 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,993,652 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 2,925,579 | May 15, 2026 |
| RICE HALL JAMES & ASSOCIATES, LLC | Increased | 2,547,255 | May 15, 2026 |
| PRIVATE MANAGEMENT GROUP INC | Increased | 2,429,166 | May 8, 2026 |
| STATE STREET CORP | Increased | 2,067,143 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 1,745,248 | May 7, 2026 |
| TOWERVIEW LLC | Unchanged | 1,000,000 | May 5, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Reduced | 959,573 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 903,799 | May 8, 2026 |
| NORTHERN TRUST CORP | Increased | 880,895 | May 14, 2026 |
| ISTHMUS PARTNERS, LLC | Increased | 756,674 | Apr 30, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 725,608 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 3, 2026